257 related articles for article (PubMed ID: 23509317)
1. New syndrome of paraganglioma and somatostatinoma associated with polycythemia.
Pacak K; Jochmanova I; Prodanov T; Yang C; Merino MJ; Fojo T; Prchal JT; Tischler AS; Lechan RM; Zhuang Z
J Clin Oncol; 2013 May; 31(13):1690-8. PubMed ID: 23509317
[TBL] [Abstract][Full Text] [Related]
2. Polycythemia and paraganglioma with a novel somatic HIF2A mutation in a male.
Toyoda H; Hirayama J; Sugimoto Y; Uchida K; Ohishi K; Hirayama M; Komada Y
Pediatrics; 2014 Jun; 133(6):e1787-91. PubMed ID: 24819565
[TBL] [Abstract][Full Text] [Related]
3. Novel insights into the polycythemia-paraganglioma-somatostatinoma syndrome.
Därr R; Nambuba J; Del Rivero J; Janssen I; Merino M; Todorovic M; Balint B; Jochmanova I; Prchal JT; Lechan RM; Tischler AS; Popovic V; Miljic D; Adams KT; Prall FR; Ling A; Golomb MR; Ferguson M; Nilubol N; Chen CC; Chew E; Taïeb D; Stratakis CA; Fojo T; Yang C; Kebebew E; Zhuang Z; Pacak K
Endocr Relat Cancer; 2016 Dec; 23(12):899-908. PubMed ID: 27679736
[TBL] [Abstract][Full Text] [Related]
4. Mosaicism in HIF2A-related polycythemia-paraganglioma syndrome.
Buffet A; Smati S; Mansuy L; Ménara M; Lebras M; Heymann MF; Simian C; Favier J; Murat A; Cariou B; Gimenez-Roqueplo AP
J Clin Endocrinol Metab; 2014 Feb; 99(2):E369-73. PubMed ID: 24276449
[TBL] [Abstract][Full Text] [Related]
5. Novel HIF2A mutations disrupt oxygen sensing, leading to polycythemia, paragangliomas, and somatostatinomas.
Yang C; Sun MG; Matro J; Huynh TT; Rahimpour S; Prchal JT; Lechan R; Lonser R; Pacak K; Zhuang Z
Blood; 2013 Mar; 121(13):2563-6. PubMed ID: 23361906
[TBL] [Abstract][Full Text] [Related]
6. First report of bilateral pheochromocytoma in the clinical spectrum of HIF2A-related polycythemia-paraganglioma syndrome.
Taïeb D; Yang C; Delenne B; Zhuang Z; Barlier A; Sebag F; Pacak K
J Clin Endocrinol Metab; 2013 May; 98(5):E908-13. PubMed ID: 23539726
[TBL] [Abstract][Full Text] [Related]
7. Nonmosaic somatic HIF2A mutations associated with late onset polycythemia-paraganglioma syndrome: Newly recognized subclass of polycythemia-paraganglioma syndrome.
Pang Y; Gupta G; Jha A; Yue X; Wang H; Huynh TT; Li A; Li L; Baker E; Chew E; Feelders RA; Korpershoek E; Zhuang Z; Yang C; Pacak K
Cancer; 2019 Apr; 125(8):1258-1266. PubMed ID: 30644531
[TBL] [Abstract][Full Text] [Related]
8. A Somatic HIF2α Mutation-Induced Multiple and Recurrent Pheochromocytoma/Paraganglioma with Polycythemia: Clinical Study with Literature Review.
Liu Q; Wang Y; Tong D; Liu G; Yuan W; Zhang J; Ye J; Zhang Y; Yuan G; Feng Q; Zhang D; Jiang J
Endocr Pathol; 2017 Mar; 28(1):75-82. PubMed ID: 28116635
[TBL] [Abstract][Full Text] [Related]
9. Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia.
Zhuang Z; Yang C; Lorenzo F; Merino M; Fojo T; Kebebew E; Popovic V; Stratakis CA; Prchal JT; Pacak K
N Engl J Med; 2012 Sep; 367(10):922-30. PubMed ID: 22931260
[TBL] [Abstract][Full Text] [Related]
10. A new twist in neuroendocrine tumor research: Pacak-Zhuang syndrome, HIF-2α as the major player in its pathogenesis and future therapeutic options.
Jochmanova I; Lazurova I
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Jun; 158(2):175-80. PubMed ID: 24781045
[TBL] [Abstract][Full Text] [Related]
11. Distinct deregulation of the hypoxia inducible factor by PHD2 mutants identified in germline DNA of patients with polycythemia.
Ladroue C; Hoogewijs D; Gad S; Carcenac R; Storti F; Barrois M; Gimenez-Roqueplo AP; Leporrier M; Casadevall N; Hermine O; Kiladjian JJ; Baruchel A; Fakhoury F; Bressac-de Paillerets B; Feunteun J; Mazure N; Pouysségur J; Wenger RH; Richard S; Gardie B
Haematologica; 2012 Jan; 97(1):9-14. PubMed ID: 21933857
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-Inducible Factor 2α Mutation-Related Paragangliomas Classify as Discrete Pseudohypoxic Subcluster.
Fliedner SM; Shankavaram U; Marzouca G; Elkahloun A; Jochmanova I; Daerr R; Linehan WM; Timmers H; Tischler AS; Papaspyrou K; Brieger J; de Krijger R; Breza J; Eisenhofer G; Zhuang Z; Lehnert H; Pacak K
Neoplasia; 2016 Sep; 18(9):567-76. PubMed ID: 27659016
[TBL] [Abstract][Full Text] [Related]
13. Ocular manifestations of hypoxia-inducible factor-2α paraganglioma-somatostatinoma-polycythemia syndrome.
Pacak K; Chew EY; Pappo AS; Yang C; Lorenzo FR; Wilson MW; Aronow MB; Young JA; Popovic V; Zhuang Z
Ophthalmology; 2014 Nov; 121(11):2291-3. PubMed ID: 25109928
[No Abstract] [Full Text] [Related]
14. In vivo and in vitro oncogenic effects of HIF2A mutations in pheochromocytomas and paragangliomas.
Toledo RA; Qin Y; Srikantan S; Morales NP; Li Q; Deng Y; Kim SW; Pereira MA; Toledo SP; Su X; Aguiar RC; Dahia PL
Endocr Relat Cancer; 2013 Jun; 20(3):349-59. PubMed ID: 23533246
[TBL] [Abstract][Full Text] [Related]
15. Germ-line PHD1 and PHD2 mutations detected in patients with pheochromocytoma/paraganglioma-polycythemia.
Yang C; Zhuang Z; Fliedner SM; Shankavaram U; Sun MG; Bullova P; Zhu R; Elkahloun AG; Kourlas PJ; Merino M; Kebebew E; Pacak K
J Mol Med (Berl); 2015 Jan; 93(1):93-104. PubMed ID: 25263965
[TBL] [Abstract][Full Text] [Related]
16. A novel EPAS1/HIF2A germline mutation in a congenital polycythemia with paraganglioma.
Lorenzo FR; Yang C; Ng Tang Fui M; Vankayalapati H; Zhuang Z; Huynh T; Grossmann M; Pacak K; Prchal JT
J Mol Med (Berl); 2013 Apr; 91(4):507-12. PubMed ID: 23090011
[TBL] [Abstract][Full Text] [Related]
17. Functional Imaging Signature of Patients Presenting with Polycythemia/Paraganglioma Syndromes.
Janssen I; Chen CC; Zhuang Z; Millo CM; Wolf KI; Ling A; Lin FI; Adams KT; Herscovitch P; Feelders RA; Fojo AT; Taieb D; Kebebew E; Pacak K
J Nucl Med; 2017 Aug; 58(8):1236-1242. PubMed ID: 28336782
[TBL] [Abstract][Full Text] [Related]
18. A novel germline gain-of-function HIF2A mutation in hepatocellular carcinoma with polycythemia.
Yu J; Shi X; Yang C; Bullova P; Hong CS; Nesvick CL; Dmitriev P; Pacak K; Zhuang Z; Cao H; Li L
Aging (Albany NY); 2020 Apr; 12(7):5781-5791. PubMed ID: 32235007
[TBL] [Abstract][Full Text] [Related]
19. A novel splicing site IRP1 somatic mutation in a patient with pheochromocytoma and JAK2
Pang Y; Gupta G; Yang C; Wang H; Huynh TT; Abdullaev Z; Pack SD; Percy MJ; Lappin TRJ; Zhuang Z; Pacak K
BMC Cancer; 2018 Mar; 18(1):286. PubMed ID: 29534684
[TBL] [Abstract][Full Text] [Related]
20. Somatic gain-of-function HIF2A mutations in sporadic central nervous system hemangioblastomas.
Taïeb D; Barlier A; Yang C; Pertuit M; Tchoghandjian A; Rochette C; Zattara-Canoni H; Figarella-Branger D; Zhuang Z; Pacak K; Metellus P
J Neurooncol; 2016 Feb; 126(3):473-81. PubMed ID: 26514359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]